Introduction
Numerous illnesses and several deaths have occurred from L. monocytogenes contamination of ready-to-eat (RTE) processed meats such as frankfurters. L. monocytogenes is a hardy organism that is difficult to eradicate from the environment and most often contaminates processed meats after cooking and before packaging. Pediocin, a compound produced by lactic acid bacteria, is a significant microbial inhibitor and may offer enhanced protection from L. monocytogene in RTE meat products.
Materials and Methods
Frankfurters were manufacturered, cooked, smoked and chilled in preparation for inoculation and packaging. For packaging, frankfurters were placed in high-barrier bags, sprayed with a 40% solution of pediocin (ALTA™ 2341) to result in 3000 AU or 6000 AU of pediocin, and then inoculated with a 5-strain mixture of L. monocytogenes. After sealing, packages were then separated into groups to be stored at 4°C, 10°C and 25°C.
Packages were opened periodically during storage and surviving L. monocytogenes enumerated at each temperature. Uninoculated frankfurters were also evaluated for quality changes including purge, color and sensory quality.
Results and Discussion
Application of the pediocin (ALTA™ 2341) immediately reduced L. monocytogenes populations by 1.5 to 2.0 log CFU/g in a concentration-dependent manner. Further, the pediocin treatment delayed growth of survivors for 7 weeks at 4°C, 2 weeks at 10°C and 1 day at 25°C. Figure 1 shows the results for both L. monocytogenes and aerobic bacteria on frankfurters stored at 10°C. There was no difference in effectiveness between the two concentrations of the pediocin during storage at 10°C but a reduction in the initial number of organisms plus a delay in growth of the survivors for the first 2 weeks is clearly evident.
Quality evaluations of uninoculated frankfurters treated with the pediocin showed that color was slightly darker and redder but all other quality characteristics were unaffected. Consequently, treatment of frankfurters with pediocin (ALTA™2341) can provide an intervention step to reduce the risk of L. monocytogenes on these products. 
